SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-13-000522
Filing Date
2013-03-18
Accepted
2013-03-18 16:31:05
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 medizone10k123112.htm 10-K 1052269
2 ex31-1.htm EX-31.1 11959
3 ex31-2.htm EX-31.2 11891
4 ex32-1.htm EX-32.1 5981
5 ex32-2.htm EX-32.2 5650
  Complete submission text file 0001185185-13-000522.txt   5326018

Data Files

Seq Description Document Type Size
6 mzei-20121231.xml EX-101.INS 754877
7 mzei-20121231.xsd EX-101.SCH 51669
8 mzei-20121231_cal.xml EX-101.CAL 31360
9 mzei-20121231_def.xml EX-101.DEF 258908
10 mzei-20121231_lab.xml EX-101.LAB 339384
11 mzei-20121231_pre.xml EX-101.PRE 261535
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 002-93277-D | Film No.: 13698051
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries